维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Doihara H"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Utility of vesselsealing systems in thyroid surgery 显示文摘	Fujita T Doihara H Ogasawara Y	2006	Acta Med Okayama2006，60，2：	1
2	Gefitinib, an epidermal growth factor receptor blockade agent, shows additional or synergistic effects on the radiosensitivity of esophageal cancer ceils in vitro 显示文摘	Taira N Doihara H Oota T	2006	Acta Med Okayama2006，60，1：	1
3	PLC and PI3K pathways are important in the inhibition of EGF-induced cell migration by gefitinib (' Iressa', ZD1839)显示文摘	SHIEN T DOIHARA H HARA H	2004	Breast Cancer2004，11，4：	1
4	PTEN activity could be a predictive marker of trastuzumah efficacy in the treatment of ErbB2-overexpressing breast cancer 显示文摘	Fujita T Doihara H Kawasaki K	2006	Br J Cancer2006，94，2：	1
5	Proteasome inhibitor bortezomib increases PTEN expression and enhances trastuzumnh-induced growth inhibition in trastuzumab-resistant cells 显示文摘	Fujita T Doihara H Washio K	2006	Anticancer Drugs2006，17，4：	1
6	Caveolin-1 as tumor suppressor gene in breast cancer显示文摘	Hino M Doihara H Kobayashi K	2003	Surg Today2003，33，7：	1
7	Antitumor effect of gefitinib ( Lres-sa) on esophageal squamous cell carcinoma cell lines in vitro and in vi-vo显示文摘	Hara F Aoe M Doihara H	2005	Cancer Lett2005，226，1：	1
8	Gefitinib,an epidermal growth factor receptor blockade agent, shows additional or synergistic effects on the radiosensitivity of esophageal cancer cells in vitro显示文摘	Taira N Doihara H Oota T	2006	Acta Med Okayama2006，60，1：	1
9	Proteasome inhibitor bortezomib increases PTEN expression and enhances trastuzumabinduced growth inhibition in trastuzumabresistant cells显示文摘	Fujita T Doihara H Washio K	2006	Anti Cancer Drugs2006，17，4：	1
10	Gefitinib, an epidermal growth factor receptor blockade agent, shows additional or syn- ergistic effects on the radiosensitivity of esophageal cancer cells in vitro 显示文摘	Taira N Doihara H Oota T	2006	Acta Medica Okayama2006，60，：	1
11	Dissection of the APCCdhl Skp2 cascade in breast cancer 显示文摘	Fujita T Liu WJ Doihara H	2008	Clin Cancer Res2008，14，7：	1
12	An in vivo study of Cdhl/APC in breast cancer formation 显示文摘	Fujita T Liu WJ Doihara H	2009	Int J Cancer2009，125，4：	1
13	Prognostic value of vascular endothelial growth factor expression in primary lung carcinoma显示文摘	Sheng H Aoe M Doihara H	2000	Acta Med Okayama2000，54，3：	1
14	Regulation of skp2-p27 axis by the Cdhl/anaphase-promoting complex pathway in colorectal tu- morigenesis 显示文摘	Fujita T Liu W Doihara H	2008	Am J Patho12008，173，1：	1
15	PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2 -overexpression breast cancer显示文摘	Fujita T Doihara H Kawasaki K	2006	Br J Cancer2006，94，2：	1
16	TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells 显示文摘	Nozawa K Kawabata-Shoda E Doihara H	2009	Proc Natl Acad Sei USA2009，106，9：	1
17	Proteasome inhibitor bortezomib increases PTEN expression and enhances trastuzumab?induced growth inhibition in trastuzumab-resistant cells显示文摘	Fujita T Doihara H Washio K	2006	Antican?cer Drugs2006，17，4：	1
18	Antitumor effect of gefitinib (Iressa) on esophageal squamous cell carcinoma cell lines in vitro and vivo显示文摘	Hara F Aoe M Doihara H	2005	Cancer Lett2005，226，1：	1
19	Caveolin-1 as tumor suppressor gene in breast cancer 显示文摘	Hino M Doihara H Kobayashi K	2003	Surg Today2003，33，7：	1
20	Gefitinib,an epidermal growth factor receptor blockade agent,shows additional or synergistic effects on the radiosensitivity of esophageal cancer cells in vitro显示文摘	Taira N Doihara H Oota T	2006	Acta Med Okayama2006，60，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示